Guifu Dihuang Pills Ameliorated Mucus Hypersecretion by Suppressing Muc5ac Expression and Inactivating the ERK-SP1 Pathway in Lipopolysaccharide/Cigarette Smoke-Induced Mice

<div>Summary diagram showing the protective effects of GFDHP against LPS/CS-induced airway inflammation and mucus hypersecretion through the suppression of Muc5ac expression and inactivation of the ERK-SP1 pathway.</div>

Evidence-Based Complementary and Alternative Medicine

fig9

Figure 9

Figure 9: Guifu Dihuang Pills Ameliorated Mucus Hypersecretion by Suppressing Muc5ac Expression and Inactivating the ERK-SP1 Pathway in Lipopolysaccharide/Cigarette Smoke-Induced Mice 

Figure 9 | Guifu Dihuang Pills Ameliorated Mucus Hypersecretion by Suppressing Muc5ac Expression and Inactivating the ERK-SP1 Pathway in Lipopolysaccharide/Cigarette Smoke-Induced Mice 